{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:32:50Z","timestamp":1783567970347,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sj\u00f6gren\u2019s disease (SjD) is an autoimmune disorder characterized by salivary gland dysfunction and systemic manifestations. This study aimed to evaluate kynurenine (Kyn) pathway metabolites in saliva and investigate their clinical relevance in SjD. Saliva samples were collected from 39 SjD patients and 32 healthy controls (HCs). Concentrations of tryptophan, Kyn, quinolinic acid (QA), and kynurenic acid (KA), as well as inferred enzyme activities, were measured using ELISA. Receiver operating characteristic curve analyses were conducted, and correlations with disease activity indices and unstimulated whole salivary flow rates (UWSFR), were assessed. SjD patients exhibited significantly higher salivary KA levels (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and lower QA levels (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) compared with HCs. Ratios of QA to Kyn and KA to Kyn were also significantly altered in the SjD group. Salivary QA demonstrated excellent discriminatory ability (area under the curve\u2009&gt;\u20090.85, sensitivity 0.87, specificity 0.76,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) for distinguishing SjD from HCs. Among various clinical parameters, salivary QA levels showed a strong inverse correlation with UWSFR (\n                    <jats:italic>r<\/jats:italic>\n                    = \u2212 0.596,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Salivary Kyn pathway metabolites, particularly QA, may serve as non-invasive biomarkers reflecting salivary gland dysfunction in SjD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-24287-y","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T13:48:28Z","timestamp":1763473708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Salivary kynurenine pathway metabolites as potential non-invasive markers of glandular dysfunction in Sj\u00f6gren\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Youngjae","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Seok","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hee","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Jooha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan\u2011Uk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"24287_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette, X. & Criswell, L. A. Primary Sj\u00f6gren\u2019s syndrome. N Engl. J. Med. 378, 931\u2013939 (2018).","journal-title":"N Engl. J. Med."},{"key":"24287_CR2","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n, P. et al. Sj\u00f6gren syndrome. Nat. Rev. Dis. Primers. 2, 16047 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"24287_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini, C., Fulvio, G., La Rocca, G. & Ferro, F. Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 20, 473\u2013491 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"24287_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly, B. & Pearce, E. L. Amino assets: how amino acids support immunity. Cell. Metab. 32, 154\u2013175 (2020).","journal-title":"Cell. Metab."},{"key":"24287_CR5","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"SK Seo","year":"2023","unstructured":"Seo, S. K. & Kwon, B. Immune regulation through Tryptophan metabolism. Exp. Mol. Med. 55, 1371\u20131379 (2023).","journal-title":"Exp. Mol. Med."},{"key":"24287_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz, J. The kynurenine pathway: a finger in every pie. Mol. Psychiatry. 25, 131\u2013147 (2020).","journal-title":"Mol. Psychiatry"},{"key":"24287_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","volume":"44","author":"TW Stone","year":"2023","unstructured":"Stone, T. W. & Williams, R. O. Modulation of T cells by Tryptophan metabolites in the kynurenine pathway. Trends Pharmacol. Sci. 44, 442\u2013456 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"24287_CR8","doi-asserted-by":"publisher","first-page":"e000254","DOI":"10.1136\/lupus-2017-000254","volume":"5","author":"K \u00c5kesson","year":"2018","unstructured":"\u00c5kesson, K. et al. Kynurenine pathway is altered in patients with SLE and associated with severe fatigue. Lupus Sci. Med. 5, e000254 (2018).","journal-title":"Lupus Sci. Med."},{"key":"24287_CR9","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00726-023-03353-7","volume":"55","author":"D Eryavuz Onmaz","year":"2023","unstructured":"Eryavuz Onmaz, D., Tezcan, D., Yilmaz, S., Onmaz, M. & Unlu, A. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus. Amino Acids. 55, 1937\u20131947 (2023).","journal-title":"Amino Acids"},{"key":"24287_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ard-2023-224014","volume":"83","author":"D Moulin","year":"2024","unstructured":"Moulin, D. et al. Counteracting Tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis. Ann. Rheum. Dis. 83, 312\u2013323 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"24287_CR11","first-page":"2363","volume":"41","author":"Y Park","year":"2023","unstructured":"Park, Y. et al. Kynurenine pathway can be a potential biomarker of fatigue in primary Sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 41, 2363\u20132370 (2023).","journal-title":"Clin. Exp. Rheumatol."},{"key":"24287_CR12","first-page":"220","volume":"62","author":"J Witoszy\u0144ska-Sobkowiak","year":"2024","unstructured":"Witoszy\u0144ska-Sobkowiak, J. et al. The kynurenine pathway in patients with rheumatoid arthritis during tumor necrosis factor \u03b1 inhibitors treatment. Reumatologia 62, 220\u2013225 (2024).","journal-title":"Reumatologia"},{"key":"24287_CR13","doi-asserted-by":"publisher","first-page":"1205616","DOI":"10.3389\/fimmu.2023.1205616","volume":"14","author":"G Urbanski","year":"2023","unstructured":"Urbanski, G. et al. An immuno-lipidomic signature revealed by metabolomic and machine-learning approaches in labial salivary gland to diagnose primary Sj\u00f6gren\u2019s syndrome. Front. Immunol. 14, 1205616 (2023).","journal-title":"Front. Immunol."},{"key":"24287_CR14","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.clinsp.2024.100459","volume":"79","author":"G Piacenza Florezi","year":"2024","unstructured":"Piacenza Florezi, G. et al. Targeted saliva metabolomics in Sj\u00f6gren\u2019s syndrome. Clin. (Sao Paulo). 79, 100459 (2024).","journal-title":"Clin. (Sao Paulo)"},{"key":"24287_CR15","doi-asserted-by":"crossref","unstructured":"Shiboski, C. H. et al. American College of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthrit. Rheumatol. 69, 35\u201345 (2017).","DOI":"10.1002\/art.39859"},{"issue":"Suppl 118","key":"24287_CR16","first-page":"107","volume":"37","author":"Y Park","year":"2019","unstructured":"Park, Y. et al. Distinct clinical characteristics of anti-Ro\/SSA-negative primary Sj\u00f6gren\u2019s syndrome: data from a nationwide cohort for Sj\u00f6gren\u2019s syndrome in Korea. Clin. Exp. Rheumatol. 37 (Suppl 118), 107\u2013113 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"24287_CR17","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","volume":"1","author":"R Seror","year":"2015","unstructured":"Seror, R. et al. EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide. RMD Open. 1, e000022 (2015).","journal-title":"RMD Open."},{"key":"24287_CR18","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror, R. et al. EULAR sjogren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary sjogren\u2019s syndrome. Ann. Rheum. Dis. 70, 968\u2013972 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"24287_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2741\/4363","volume":"20","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Liu, D., Song, P. & Zou, M. H. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. Front. Biosci. (Landmark Ed). 20, 1116\u20131143 (2015).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"24287_CR20","doi-asserted-by":"publisher","first-page":"1070435","DOI":"10.3389\/fnut.2022.1070435","volume":"9","author":"MC Saade","year":"2022","unstructured":"Saade, M. C., Clark, A. J. & Parikh, S. M. States of quinolinic acid excess in urine: A systematic review of human studies. Front. Nutr. 9, 1070435 (2022).","journal-title":"Front. Nutr."},{"key":"24287_CR21","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1038\/s41598-024-57154-3","volume":"14","author":"A Krupa","year":"2024","unstructured":"Krupa, A., \u0141ebkowska, A., Kondraciuk, M., Kaminski, K. A. & Kowalska I. Alteration in kynurenine pathway metabolites in young women with autoimmune thyroiditis. Sci. Rep. 14, 6851 (2024).","journal-title":"Sci. Rep."},{"key":"24287_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.019","volume":"94","author":"AM Garrison","year":"2018","unstructured":"Garrison, A. M. et al. Kynurenine pathway metabolic balance influences microglia activity: targeting kynurenine monooxygenase to dampen neuroinflammation. Psychoneuroendocrinology 94, 1\u201310 (2018).","journal-title":"Psychoneuroendocrinology"},{"key":"24287_CR23","doi-asserted-by":"crossref","unstructured":"Tanaka, M. et al. Immune influencers in action: metabolites and enzymes of the Tryptophan-Kynurenine metabolic pathway. Biomedicines 9 (2021).","DOI":"10.20944\/preprints202106.0344.v1"},{"key":"24287_CR24","doi-asserted-by":"crossref","unstructured":"Lugo-Huitr\u00f3n, R. et al. Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxid. Med. Cell Longev. 104024 (2013).","DOI":"10.1155\/2013\/104024"},{"key":"24287_CR25","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas, C. et al. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21, 7463\u20137473 (2001).","journal-title":"J. Neurosci."},{"key":"24287_CR26","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J. Biol. Chem. 281, 22021\u201322028 (2006).","journal-title":"J. Biol. Chem."},{"key":"24287_CR27","doi-asserted-by":"publisher","first-page":"101573","DOI":"10.1016\/j.arr.2022.101573","volume":"75","author":"A Salminen","year":"2022","unstructured":"Salminen, A. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res. Rev. 75, 101573 (2022).","journal-title":"Ageing Res. Rev."},{"key":"24287_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","volume":"34","author":"DH Munn","year":"2013","unstructured":"Munn, D. H. & Mellor, A. L. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 34, 137\u2013143 (2013).","journal-title":"Trends Immunol."},{"key":"24287_CR29","doi-asserted-by":"publisher","first-page":"7266","DOI":"10.1021\/bi992997s","volume":"39","author":"LE Goldstein","year":"2000","unstructured":"Goldstein, L. E. et al. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 39, 7266\u20137275 (2000).","journal-title":"Biochemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24287-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T02:02:37Z","timestamp":1763863357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24287-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24287"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24287-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40539"}}